Small Molecules

08 Jan 2007 INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for INNO-406 for the Treatment of Chronic Myelogenous Leukemia
06 Jan 2007 OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
06 Jan 2007 Hypnion, Inc. Announces Positive And Robust Phase II Results For Novel Sleep Drug - HY10275
06 Jan 2007 TargeGen Selects Jak2 Inhibitor Lead (TG101348) for Clinical Development as a Potential Therapy for Myeloproliferative Diseases Including Polycythemia Vera (PV)
05 Jan 2007 Medivir Files Clinical Trial Application To Start Phase I With MIV-701
05 Jan 2007 Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
05 Jan 2007 Pharmacopeia Enters into a Research and License Agreement with Wyeth to Develop Novel JAK3 Inhibitors for the Treatment of Immunological and Inflammatory Diseases
05 Jan 2007 Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
05 Jan 2007 Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
05 Jan 2007 Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
05 Jan 2007 AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
05 Jan 2007 Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005
05 Jan 2007 BiPar Sciences Begins Enrollment in Phase 1b Study of BSI-201
05 Jan 2007 Neosil Announces Positive Phase 2 Data for NEOSH101, an Investigational Treatment for Androgenetic Alopecia
05 Jan 2007 Enzon Pharmaceuticals Files Investigational New Drug Application for Novel HIF-1alpha Antagonist in Cancer
05 Jan 2007 BioMarin Initiates Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease
04 Jan 2007 Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
04 Jan 2007 D-Pharm announces positive Phase IIb trial results for DP-b99 in acute stroke patients
04 Jan 2007 Theravance Initiates Phase 2 Clinical Program with Investigational Heterodimer Antibiotic
04 Jan 2007 Catalyst Pharmaceutical Partners Provides an Update on Its Clinical Development Plans for CPP-109
04 Jan 2007 Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
04 Jan 2007 DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
04 Jan 2007 Poniard Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase 3 Trial of Picoplatin for Small Cell Lung Cancer
04 Jan 2007 Genaera Corporation Terminates Evizon(TM) Clinical Program And Restructures
03 Jan 2007 Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top